Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by MirrorWorldManon Feb 24, 2021 12:38pm
140 Views
Post# 32647769

RE:Quarterly Update

RE:Quarterly UpdateLets see if I can decipher  "HowieTalk"
WannaBang has finished phase 1 with our SGLT2, hooray after 8 years...  We also need more time again for something to do with potential partners doing their due diligence or whatever again.  New indications for weight loss or slowing renal decline is something we are looking at too (yawn).  That will take a few million dollars of phase 3 trials and another 20 years to show at this pace.
They confirmed that Huaxi is indeed off the table as a China partner, this was hinted at from the last update but it usually takes Howie a few updates to finally come clean.  But do not worry, there is always another un-named potential partner that is seeking interest in us...
Looks like they have another investor package to hand out from their booth at conferences.  Anyone remember the fancy USB folder they were given out years ago?  Well now its been augmented with more stuff...
Looks like they will be spending more money to improve production scale up processes.
Looks like they abondoned their current lead ant-aging candidate and now looking at beginning the process again with a bunch more Anti-Aging molecules they produced in the lab and found a new lead.  What the heck?  This is reminicient of when Howie patented a handful of other skin lighters a few years ago that resulted in nothing.
The .4% trial is completed but the results are proprietory to someone else.
So bottom line is like an old record, everthing is just taking more time, some unexpected delays but Howie is hopeful all will be well in his head someday.

<< Previous
Bullboard Posts
Next >>